

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosome assembly (GO:0042255) | 4.01764807 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.95909957 |
| 3 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.93562839 |
| 4 | positive regulation of interferon-alpha production (GO:0032727) | 3.92925637 |
| 5 | immunoglobulin mediated immune response (GO:0016064) | 3.85498555 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.75187632 |
| 7 | regulation of interferon-alpha production (GO:0032647) | 3.72382195 |
| 8 | cullin deneddylation (GO:0010388) | 3.71133798 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.65018784 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 3.60012973 |
| 11 | respiratory chain complex IV assembly (GO:0008535) | 3.58154224 |
| 12 | platelet dense granule organization (GO:0060155) | 3.53201745 |
| 13 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.47224929 |
| 14 | protein deneddylation (GO:0000338) | 3.46548854 |
| 15 | B cell mediated immunity (GO:0019724) | 3.44628083 |
| 16 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.41659675 |
| 17 | interferon-gamma secretion (GO:0072643) | 3.38641818 |
| 18 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.36172833 |
| 19 | DNA double-strand break processing (GO:0000729) | 3.33830537 |
| 20 | formation of translation preinitiation complex (GO:0001731) | 3.28944128 |
| 21 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.26402633 |
| 22 | CENP-A containing nucleosome assembly (GO:0034080) | 3.25998484 |
| 23 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.24541011 |
| 24 | modulation by symbiont of host immune response (GO:0052553) | 3.24541011 |
| 25 | positive regulation by symbiont of host defense response (GO:0052509) | 3.24541011 |
| 26 | modulation by symbiont of host defense response (GO:0052031) | 3.24541011 |
| 27 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.24541011 |
| 28 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.24541011 |
| 29 | proteasome assembly (GO:0043248) | 3.24262172 |
| 30 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.23086500 |
| 31 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.21687184 |
| 32 | amino sugar catabolic process (GO:0046348) | 3.21178205 |
| 33 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.19238149 |
| 34 | protein neddylation (GO:0045116) | 3.15570812 |
| 35 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.14427583 |
| 36 | chromatin remodeling at centromere (GO:0031055) | 3.12410992 |
| 37 | positive regulation of interferon-beta production (GO:0032728) | 3.09630602 |
| 38 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.09109413 |
| 39 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.09109413 |
| 40 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.08593670 |
| 41 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.08593670 |
| 42 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.08593670 |
| 43 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.07837446 |
| 44 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.06525220 |
| 45 | DNA ligation (GO:0006266) | 3.06283217 |
| 46 | pinocytosis (GO:0006907) | 3.06047971 |
| 47 | lactate metabolic process (GO:0006089) | 3.05334265 |
| 48 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.04028128 |
| 49 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.04028128 |
| 50 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.03973910 |
| 51 | cytochrome complex assembly (GO:0017004) | 3.03930188 |
| 52 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.03048859 |
| 53 | natural killer cell mediated immunity (GO:0002228) | 3.02640954 |
| 54 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.02640954 |
| 55 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.02038495 |
| 56 | negative regulation of ligase activity (GO:0051352) | 3.02038495 |
| 57 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.99976119 |
| 58 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.96846279 |
| 59 | B cell receptor signaling pathway (GO:0050853) | 2.94504682 |
| 60 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.93831785 |
| 61 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 2.93078141 |
| 62 | rRNA modification (GO:0000154) | 2.90636020 |
| 63 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.89928801 |
| 64 | purine nucleobase biosynthetic process (GO:0009113) | 2.87073733 |
| 65 | actin nucleation (GO:0045010) | 2.83764548 |
| 66 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.83340586 |
| 67 | respiratory burst (GO:0045730) | 2.83010662 |
| 68 | negative regulation of protein ubiquitination (GO:0031397) | 2.82997326 |
| 69 | regulation of ligase activity (GO:0051340) | 2.81264139 |
| 70 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.80992823 |
| 71 | positive regulation of B cell differentiation (GO:0045579) | 2.79992590 |
| 72 | hepatocyte apoptotic process (GO:0097284) | 2.79788253 |
| 73 | cellular response to interferon-alpha (GO:0035457) | 2.78998965 |
| 74 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.78599249 |
| 75 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.78599249 |
| 76 | histone mRNA metabolic process (GO:0008334) | 2.76605632 |
| 77 | transcription from mitochondrial promoter (GO:0006390) | 2.75426742 |
| 78 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.75413715 |
| 79 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.75413715 |
| 80 | isotype switching (GO:0045190) | 2.75413715 |
| 81 | positive regulation of ligase activity (GO:0051351) | 2.73395227 |
| 82 | histone exchange (GO:0043486) | 2.73219214 |
| 83 | branched-chain amino acid catabolic process (GO:0009083) | 2.71675802 |
| 84 | regulation of RIG-I signaling pathway (GO:0039535) | 2.71074837 |
| 85 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 2.69842127 |
| 86 | metaphase plate congression (GO:0051310) | 2.69445507 |
| 87 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.68535301 |
| 88 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.68125564 |
| 89 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.68125564 |
| 90 | regulation of translation in response to stress (GO:0043555) | 2.68071025 |
| 91 | nucleobase biosynthetic process (GO:0046112) | 2.67731190 |
| 92 | cellular response to interferon-beta (GO:0035458) | 2.67399221 |
| 93 | folic acid transport (GO:0015884) | 2.67149277 |
| 94 | type I interferon signaling pathway (GO:0060337) | 2.67098015 |
| 95 | cellular response to type I interferon (GO:0071357) | 2.67098015 |
| 96 | mitochondrial DNA replication (GO:0006264) | 2.66127623 |
| 97 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.65751074 |
| 98 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.65751074 |
| 99 | cell wall macromolecule catabolic process (GO:0016998) | 2.65052854 |
| 100 | regulation of interferon-beta production (GO:0032648) | 2.63932075 |
| 101 | response to type I interferon (GO:0034340) | 2.63468998 |
| 102 | rRNA methylation (GO:0031167) | 2.63023321 |
| 103 | positive regulation of cell cycle arrest (GO:0071158) | 2.62787721 |
| 104 | telomere maintenance via recombination (GO:0000722) | 2.62644588 |
| 105 | regulation of B cell differentiation (GO:0045577) | 2.62014116 |
| 106 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.61812416 |
| 107 | response to hydroperoxide (GO:0033194) | 2.58713271 |
| 108 | response to peptidoglycan (GO:0032494) | 2.58100662 |
| 109 | mitochondrial RNA metabolic process (GO:0000959) | 2.58055129 |
| 110 | IMP biosynthetic process (GO:0006188) | 2.58013121 |
| 111 | regulation of cellular amine metabolic process (GO:0033238) | 2.57467638 |
| 112 | response to interferon-alpha (GO:0035455) | 2.56901352 |
| 113 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.55114069 |
| 114 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.54812652 |
| 115 | lymphocyte mediated immunity (GO:0002449) | 2.54434570 |
| 116 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.53786465 |
| 117 | tricarboxylic acid cycle (GO:0006099) | 2.53596498 |
| 118 | purine-containing compound salvage (GO:0043101) | 2.53066930 |
| 119 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.52637749 |
| 120 | regulation of helicase activity (GO:0051095) | 2.52104278 |
| 121 | response to protozoan (GO:0001562) | 2.51427634 |
| 122 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.51140514 |
| 123 | protein complex biogenesis (GO:0070271) | 2.49589248 |
| 124 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.49207330 |
| 125 | establishment of integrated proviral latency (GO:0075713) | 2.49194406 |
| 126 | macrophage activation involved in immune response (GO:0002281) | 2.48746140 |
| 127 | establishment of chromosome localization (GO:0051303) | 2.44655453 |
| 128 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.44139292 |
| 129 | regulation of meiosis I (GO:0060631) | 2.43992254 |
| 130 | defense response to protozoan (GO:0042832) | 2.42868909 |
| 131 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.42841680 |
| 132 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.42794447 |
| 133 | mitotic recombination (GO:0006312) | 2.42651618 |
| 134 | cyclooxygenase pathway (GO:0019371) | 2.42284587 |
| 135 | cellular response to zinc ion (GO:0071294) | 2.42042197 |
| 136 | folic acid metabolic process (GO:0046655) | 2.41937695 |
| 137 | protein K11-linked ubiquitination (GO:0070979) | 2.41848753 |
| 138 | mitotic metaphase plate congression (GO:0007080) | 2.41304194 |
| 139 | response to interferon-beta (GO:0035456) | 2.41266026 |
| 140 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.40870353 |
| 141 | DNA strand elongation (GO:0022616) | 2.40857301 |
| 142 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.40216592 |
| 143 | mitotic spindle checkpoint (GO:0071174) | 2.40050940 |
| 144 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.39573423 |
| 145 | signal transduction in response to DNA damage (GO:0042770) | 2.39011394 |
| 146 | DNA deamination (GO:0045006) | 2.39010842 |
| 147 | neutrophil activation (GO:0042119) | 2.38994644 |
| 148 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.38691834 |
| 149 | spindle checkpoint (GO:0031577) | 2.38457891 |
| 150 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.38142355 |
| 151 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.38142355 |
| 152 | NADH dehydrogenase complex assembly (GO:0010257) | 2.38142355 |
| 153 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.38095599 |
| 154 | N-acetylneuraminate metabolic process (GO:0006054) | 2.37497923 |
| 155 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.37483523 |
| 156 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.36113979 |
| 157 | positive regulation of mast cell degranulation (GO:0043306) | 2.36113979 |
| 158 | positive regulation of antigen processing and presentation (GO:0002579) | 2.35755296 |
| 159 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.35307755 |
| 160 | cell cycle G1/S phase transition (GO:0044843) | 2.35307755 |
| 161 | oxidative phosphorylation (GO:0006119) | 2.33655755 |
| 162 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.33515805 |
| 163 | protein localization to kinetochore (GO:0034501) | 2.33000593 |
| 164 | histone-serine phosphorylation (GO:0035404) | 2.32838047 |
| 165 | leukocyte mediated cytotoxicity (GO:0001909) | 2.32557739 |
| 166 | DNA replication checkpoint (GO:0000076) | 2.32146012 |
| 167 | regulation of histone H3-K27 methylation (GO:0061085) | 2.31414569 |
| 168 | histamine secretion (GO:0001821) | 2.31359261 |
| 169 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2.31199403 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.33713193 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.13315322 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.87938591 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.81573262 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.76373486 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.56863065 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.53256967 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.50338606 |
| 9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.49476645 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.46290673 |
| 11 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.43338171 |
| 12 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.41299659 |
| 13 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.39734069 |
| 14 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.27515830 |
| 15 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.25108724 |
| 16 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.24898227 |
| 17 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.19617511 |
| 18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.18368336 |
| 19 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.15919247 |
| 20 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.10009060 |
| 21 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.05641583 |
| 22 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.98961170 |
| 23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.95364476 |
| 24 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.93645250 |
| 25 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.88911501 |
| 26 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.84704640 |
| 27 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.84692681 |
| 28 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.84194228 |
| 29 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.84151704 |
| 30 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.83912652 |
| 31 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.81775797 |
| 32 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.80748684 |
| 33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78202330 |
| 34 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.74802795 |
| 35 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.74023078 |
| 36 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.73547170 |
| 37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.70327134 |
| 38 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.69526039 |
| 39 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.69467304 |
| 40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.67846378 |
| 41 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.66859146 |
| 42 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.65073005 |
| 43 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.62857909 |
| 44 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.60416097 |
| 45 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.60093203 |
| 46 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.59404559 |
| 47 | EWS_26573619_Chip-Seq_HEK293_Human | 1.55476123 |
| 48 | VDR_22108803_ChIP-Seq_LS180_Human | 1.55422796 |
| 49 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.54306761 |
| 50 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.53487260 |
| 51 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.50610025 |
| 52 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49774538 |
| 53 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.47131915 |
| 54 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.46109310 |
| 55 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.45332400 |
| 56 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.42819761 |
| 57 | MYC_22102868_ChIP-Seq_BL_Human | 1.42805368 |
| 58 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39816975 |
| 59 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.39762066 |
| 60 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.39601060 |
| 61 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.38652770 |
| 62 | MYB_26560356_Chip-Seq_TH2_Human | 1.37779562 |
| 63 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37366400 |
| 64 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.36717339 |
| 65 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.35121009 |
| 66 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.34953368 |
| 67 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.34549920 |
| 68 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.34147020 |
| 69 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.33909941 |
| 70 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.32474558 |
| 71 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.29898594 |
| 72 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.28954240 |
| 73 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.26573274 |
| 74 | MYB_26560356_Chip-Seq_TH1_Human | 1.25469055 |
| 75 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.25391096 |
| 76 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.25374592 |
| 77 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.24778493 |
| 78 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.23529182 |
| 79 | FUS_26573619_Chip-Seq_HEK293_Human | 1.23386673 |
| 80 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.23144240 |
| 81 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.22635536 |
| 82 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.21837653 |
| 83 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.20932260 |
| 84 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.19877259 |
| 85 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.18599153 |
| 86 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.18443520 |
| 87 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.18225938 |
| 88 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.18115961 |
| 89 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.18018791 |
| 90 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.15981462 |
| 91 | MAF_26560356_Chip-Seq_TH1_Human | 1.13408188 |
| 92 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.12994609 |
| 93 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12653177 |
| 94 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.11948193 |
| 95 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.10940574 |
| 96 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.10768536 |
| 97 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.07100572 |
| 98 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.06463879 |
| 99 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.05202727 |
| 100 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.04442053 |
| 101 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.04000511 |
| 102 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.03736301 |
| 103 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.03501074 |
| 104 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.03428420 |
| 105 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.02573144 |
| 106 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.01067891 |
| 107 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.00683717 |
| 108 | GATA3_26560356_Chip-Seq_TH2_Human | 1.00276373 |
| 109 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.00034456 |
| 110 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.99045032 |
| 111 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.98802558 |
| 112 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98702593 |
| 113 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.98163341 |
| 114 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.97854835 |
| 115 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97643908 |
| 116 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.97352615 |
| 117 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.97352615 |
| 118 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.96680790 |
| 119 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.95372250 |
| 120 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.94932385 |
| 121 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94883968 |
| 122 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.94778668 |
| 123 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.93887064 |
| 124 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92725749 |
| 125 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.92557522 |
| 126 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.92548586 |
| 127 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.92246408 |
| 128 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.88025472 |
| 129 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.84163079 |
| 130 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.83914302 |
| 131 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.83760284 |
| 132 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.83224660 |
| 133 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.83011202 |
| 134 | AR_20517297_ChIP-Seq_VCAP_Human | 0.82459602 |
| 135 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.81621241 |
| 136 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.81413546 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.05553663 |
| 2 | MP0003693_abnormal_embryo_hatching | 3.47669903 |
| 3 | MP0009785_altered_susceptibility_to | 2.80290302 |
| 4 | MP0005058_abnormal_lysosome_morphology | 2.77811354 |
| 5 | MP0001800_abnormal_humoral_immune | 2.62964366 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 2.57762818 |
| 7 | MP0005671_abnormal_response_to | 2.52229381 |
| 8 | MP0002452_abnormal_antigen_presenting | 2.49022847 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.48194088 |
| 10 | MP0004957_abnormal_blastocyst_morpholog | 2.46322083 |
| 11 | MP0001790_abnormal_immune_system | 2.45267160 |
| 12 | MP0005387_immune_system_phenotype | 2.45267160 |
| 13 | MP0003436_decreased_susceptibility_to | 2.42359539 |
| 14 | MP0000685_abnormal_immune_system | 2.37755811 |
| 15 | MP0009840_abnormal_foam_cell | 2.31362037 |
| 16 | MP0002419_abnormal_innate_immunity | 2.25322627 |
| 17 | MP0005025_abnormal_response_to | 2.20348505 |
| 18 | MP0002723_abnormal_immune_serum | 2.19729789 |
| 19 | MP0003111_abnormal_nucleus_morphology | 2.17860417 |
| 20 | MP0001819_abnormal_immune_cell | 2.11753519 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.11427211 |
| 22 | MP0009697_abnormal_copulation | 1.99370617 |
| 23 | MP0006082_CNS_inflammation | 1.98509306 |
| 24 | MP0003077_abnormal_cell_cycle | 1.97951719 |
| 25 | MP0002396_abnormal_hematopoietic_system | 1.97042980 |
| 26 | MP0005075_abnormal_melanosome_morpholog | 1.93637499 |
| 27 | MP0010094_abnormal_chromosome_stability | 1.93635378 |
| 28 | MP0000516_abnormal_urinary_system | 1.90920481 |
| 29 | MP0005367_renal/urinary_system_phenotyp | 1.90920481 |
| 30 | MP0010352_gastrointestinal_tract_polyps | 1.89606558 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 1.88024260 |
| 32 | MP0002398_abnormal_bone_marrow | 1.84410591 |
| 33 | MP0008877_abnormal_DNA_methylation | 1.83376396 |
| 34 | MP0000372_irregular_coat_pigmentation | 1.75224308 |
| 35 | MP0006036_abnormal_mitochondrial_physio | 1.74862175 |
| 36 | MP0000716_abnormal_immune_system | 1.74315881 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.72045100 |
| 38 | MP0003303_peritoneal_inflammation | 1.68813155 |
| 39 | MP0003724_increased_susceptibility_to | 1.62965793 |
| 40 | MP0002722_abnormal_immune_system | 1.61100023 |
| 41 | MP0002405_respiratory_system_inflammati | 1.59002769 |
| 42 | MP0001764_abnormal_homeostasis | 1.58747104 |
| 43 | MP0002138_abnormal_hepatobiliary_system | 1.57489159 |
| 44 | MP0001853_heart_inflammation | 1.56292440 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.55123200 |
| 46 | MP0002429_abnormal_blood_cell | 1.54565579 |
| 47 | MP0001845_abnormal_inflammatory_respons | 1.54456489 |
| 48 | MP0000569_abnormal_digit_pigmentation | 1.52290477 |
| 49 | MP0004947_skin_inflammation | 1.46864565 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.46241037 |
| 51 | MP0005084_abnormal_gallbladder_morpholo | 1.44853338 |
| 52 | MP0003172_abnormal_lysosome_physiology | 1.44680122 |
| 53 | MP0008057_abnormal_DNA_replication | 1.44041412 |
| 54 | MP0010307_abnormal_tumor_latency | 1.43032331 |
| 55 | MP0008007_abnormal_cellular_replicative | 1.41989218 |
| 56 | MP0008058_abnormal_DNA_repair | 1.41594392 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.40780812 |
| 58 | MP0003448_altered_tumor_morphology | 1.39820133 |
| 59 | MP0003763_abnormal_thymus_physiology | 1.39746869 |
| 60 | MP0002102_abnormal_ear_morphology | 1.39128762 |
| 61 | MP0010155_abnormal_intestine_physiology | 1.38687193 |
| 62 | MP0004147_increased_porphyrin_level | 1.37479030 |
| 63 | MP0006035_abnormal_mitochondrial_morpho | 1.34933144 |
| 64 | MP0004808_abnormal_hematopoietic_stem | 1.33470885 |
| 65 | MP0008260_abnormal_autophagy | 1.32762483 |
| 66 | MP0003566_abnormal_cell_adhesion | 1.32590330 |
| 67 | MP0003186_abnormal_redox_activity | 1.29778274 |
| 68 | MP0008004_abnormal_stomach_pH | 1.29015081 |
| 69 | MP0006072_abnormal_retinal_apoptosis | 1.28671730 |
| 70 | MP0008469_abnormal_protein_level | 1.28154479 |
| 71 | MP0000490_abnormal_crypts_of | 1.27346029 |
| 72 | MP0006054_spinal_hemorrhage | 1.25991353 |
| 73 | MP0001545_abnormal_hematopoietic_system | 1.25208591 |
| 74 | MP0005397_hematopoietic_system_phenotyp | 1.25208591 |
| 75 | MP0000858_altered_metastatic_potential | 1.23679297 |
| 76 | MP0002166_altered_tumor_susceptibility | 1.21138794 |
| 77 | MP0003567_abnormal_fetal_cardiomyocyte | 1.20707672 |
| 78 | MP0002006_tumorigenesis | 1.18991190 |
| 79 | MP0002019_abnormal_tumor_incidence | 1.15609107 |
| 80 | MP0002837_dystrophic_cardiac_calcinosis | 1.15233123 |
| 81 | MP0005310_abnormal_salivary_gland | 1.13397621 |
| 82 | MP0005023_abnormal_wound_healing | 1.12042947 |
| 83 | MP0004782_abnormal_surfactant_physiolog | 1.11581241 |
| 84 | MP0008932_abnormal_embryonic_tissue | 1.09452067 |
| 85 | MP0000343_altered_response_to | 1.08433847 |
| 86 | MP0005253_abnormal_eye_physiology | 1.07949211 |
| 87 | MP0000703_abnormal_thymus_morphology | 1.07269656 |
| 88 | MP0005174_abnormal_tail_pigmentation | 1.07196041 |
| 89 | MP0001542_abnormal_bone_strength | 1.05517161 |
| 90 | MP0000647_abnormal_sebaceous_gland | 1.03772496 |
| 91 | MP0003718_maternal_effect | 1.03350111 |
| 92 | MP0002090_abnormal_vision | 1.02045262 |
| 93 | MP0001730_embryonic_growth_arrest | 1.00658811 |
| 94 | MP0000350_abnormal_cell_proliferation | 0.98150070 |
| 95 | MP0003866_abnormal_defecation | 0.96513797 |
| 96 | MP0004510_myositis | 0.96457467 |
| 97 | MP0003075_altered_response_to | 0.95195758 |
| 98 | MP0003806_abnormal_nucleotide_metabolis | 0.94687334 |
| 99 | MP0002139_abnormal_hepatobiliary_system | 0.92329130 |
| 100 | MP0002132_abnormal_respiratory_system | 0.88990842 |
| 101 | MP0003705_abnormal_hypodermis_morpholog | 0.88128014 |
| 102 | MP0000313_abnormal_cell_death | 0.85941920 |
| 103 | MP0002136_abnormal_kidney_physiology | 0.85558795 |
| 104 | MP0003195_calcinosis | 0.84367506 |
| 105 | MP0004215_abnormal_myocardial_fiber | 0.82966560 |
| 106 | MP0009278_abnormal_bone_marrow | 0.82351140 |
| 107 | MP0000465_gastrointestinal_hemorrhage | 0.82189868 |
| 108 | MP0000427_abnormal_hair_cycle | 0.81496354 |
| 109 | MP0002095_abnormal_skin_pigmentation | 0.80723741 |
| 110 | MP0005332_abnormal_amino_acid | 0.79944624 |
| 111 | MP0002933_joint_inflammation | 0.78829223 |
| 112 | MP0001727_abnormal_embryo_implantation | 0.78008718 |
| 113 | MP0000358_abnormal_cell_content/ | 0.77099582 |
| 114 | MP0003828_pulmonary_edema | 0.76867449 |
| 115 | MP0005076_abnormal_cell_differentiation | 0.76728535 |
| 116 | MP0001324_abnormal_eye_pigmentation | 0.76611060 |
| 117 | MP0001756_abnormal_urination | 0.76563791 |
| 118 | MP0010234_abnormal_vibrissa_follicle | 0.75892932 |
| 119 | MP0008873_increased_physiological_sensi | 0.75306235 |
| 120 | MP0008438_abnormal_cutaneous_collagen | 0.75143174 |
| 121 | MP0009764_decreased_sensitivity_to | 0.74747738 |
| 122 | MP0003011_delayed_dark_adaptation | 0.74515493 |
| 123 | MP0005636_abnormal_mineral_homeostasis | 0.72260472 |
| 124 | MP0005085_abnormal_gallbladder_physiolo | 0.71982439 |
| 125 | MP0002998_abnormal_bone_remodeling | 0.71865838 |
| 126 | MP0000015_abnormal_ear_pigmentation | 0.71182822 |
| 127 | MP0003300_gastrointestinal_ulcer | 0.69826427 |
| 128 | MP0002277_abnormal_respiratory_mucosa | 0.68837373 |
| 129 | MP0009763_increased_sensitivity_to | 0.68147422 |
| 130 | MP0005621_abnormal_cell_physiology | 0.67947341 |
| 131 | MP0003786_premature_aging | 0.67905172 |
| 132 | MP0005390_skeleton_phenotype | 0.67588203 |
| 133 | MP0005166_decreased_susceptibility_to | 0.65226584 |
| 134 | MP0009643_abnormal_urine_homeostasis | 0.65062437 |
| 135 | MP0000598_abnormal_liver_morphology | 0.63578622 |
| 136 | MP0005395_other_phenotype | 0.63547771 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.32184928 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.95822612 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.73027970 |
| 4 | Vacuolated lymphocytes (HP:0001922) | 4.11868264 |
| 5 | Abnormality of macrophages (HP:0004311) | 3.78588804 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 3.75509263 |
| 7 | Cellulitis (HP:0100658) | 3.66221237 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 3.58141574 |
| 9 | Agammaglobulinemia (HP:0004432) | 3.45882829 |
| 10 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.45355624 |
| 11 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.45355624 |
| 12 | Abnormality of glycolipid metabolism (HP:0010969) | 3.45355624 |
| 13 | Poor head control (HP:0002421) | 3.43806153 |
| 14 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.42032626 |
| 15 | Acute necrotizing encephalopathy (HP:0006965) | 3.40940135 |
| 16 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.37059038 |
| 17 | IgM deficiency (HP:0002850) | 3.27314182 |
| 18 | Autoimmune thrombocytopenia (HP:0001973) | 3.26258252 |
| 19 | Increased CSF lactate (HP:0002490) | 3.25075273 |
| 20 | Progressive macrocephaly (HP:0004481) | 3.22110093 |
| 21 | Agnosia (HP:0010524) | 3.14110350 |
| 22 | Pustule (HP:0200039) | 3.12260368 |
| 23 | Recurrent bronchitis (HP:0002837) | 3.07912248 |
| 24 | Recurrent pneumonia (HP:0006532) | 3.06579997 |
| 25 | Recurrent viral infections (HP:0004429) | 3.05896010 |
| 26 | Mitochondrial inheritance (HP:0001427) | 3.05441165 |
| 27 | Acute encephalopathy (HP:0006846) | 3.04813676 |
| 28 | Osteomyelitis (HP:0002754) | 3.02710971 |
| 29 | 3-Methylglutaconic aciduria (HP:0003535) | 2.99830931 |
| 30 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.98405783 |
| 31 | Recurrent fungal infections (HP:0002841) | 2.92767903 |
| 32 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.92408259 |
| 33 | Petechiae (HP:0000967) | 2.88007423 |
| 34 | Hepatocellular necrosis (HP:0001404) | 2.84655595 |
| 35 | Type I transferrin isoform profile (HP:0003642) | 2.84317021 |
| 36 | Abnormality of the anterior horn cell (HP:0006802) | 2.82667653 |
| 37 | Degeneration of anterior horn cells (HP:0002398) | 2.82667653 |
| 38 | Hepatic necrosis (HP:0002605) | 2.82077336 |
| 39 | Prolonged neonatal jaundice (HP:0006579) | 2.81167360 |
| 40 | Microvesicular hepatic steatosis (HP:0001414) | 2.78654713 |
| 41 | Interstitial pulmonary disease (HP:0006530) | 2.78146845 |
| 42 | Chronic obstructive pulmonary disease (HP:0006510) | 2.77079442 |
| 43 | Obstructive lung disease (HP:0006536) | 2.77079442 |
| 44 | Recurrent lower respiratory tract infections (HP:0002783) | 2.75287321 |
| 45 | Mediastinal lymphadenopathy (HP:0100721) | 2.74684961 |
| 46 | Recurrent skin infections (HP:0001581) | 2.70083512 |
| 47 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.65038607 |
| 48 | Abnormality of alanine metabolism (HP:0010916) | 2.65038607 |
| 49 | Hyperalaninemia (HP:0003348) | 2.65038607 |
| 50 | Methylmalonic acidemia (HP:0002912) | 2.62890679 |
| 51 | Myositis (HP:0100614) | 2.62306601 |
| 52 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.60867520 |
| 53 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.60867520 |
| 54 | Abnormal protein glycosylation (HP:0012346) | 2.60867520 |
| 55 | Abnormal glycosylation (HP:0012345) | 2.60867520 |
| 56 | Meningitis (HP:0001287) | 2.59381200 |
| 57 | Basal ganglia calcification (HP:0002135) | 2.58762978 |
| 58 | Cerebral edema (HP:0002181) | 2.58535848 |
| 59 | Vasculitis (HP:0002633) | 2.55699728 |
| 60 | Abnormality of methionine metabolism (HP:0010901) | 2.46005097 |
| 61 | Neoplasm of the adrenal gland (HP:0100631) | 2.45814559 |
| 62 | Eosinophilia (HP:0001880) | 2.45444209 |
| 63 | Lactic acidosis (HP:0003128) | 2.44596165 |
| 64 | Increased serum lactate (HP:0002151) | 2.44090814 |
| 65 | IgG deficiency (HP:0004315) | 2.43611810 |
| 66 | Reduced antithrombin III activity (HP:0001976) | 2.43257709 |
| 67 | Increased serum pyruvate (HP:0003542) | 2.42430423 |
| 68 | Abnormality of T cell physiology (HP:0011840) | 2.41551569 |
| 69 | Abnormality of the prostate (HP:0008775) | 2.40765121 |
| 70 | IgA deficiency (HP:0002720) | 2.40297409 |
| 71 | B lymphocytopenia (HP:0010976) | 2.40193681 |
| 72 | Abnormality of B cell number (HP:0010975) | 2.40193681 |
| 73 | Abolished electroretinogram (ERG) (HP:0000550) | 2.38285455 |
| 74 | Lymphopenia (HP:0001888) | 2.37262051 |
| 75 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.37148712 |
| 76 | Abnormality of T cells (HP:0002843) | 2.36787006 |
| 77 | Granulocytopenia (HP:0001913) | 2.35892861 |
| 78 | Chronic otitis media (HP:0000389) | 2.34487583 |
| 79 | Increased hepatocellular lipid droplets (HP:0006565) | 2.34220934 |
| 80 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.34143299 |
| 81 | Combined immunodeficiency (HP:0005387) | 2.33848998 |
| 82 | Anorexia (HP:0002039) | 2.33490054 |
| 83 | Gastrointestinal stroma tumor (HP:0100723) | 2.32156850 |
| 84 | Respiratory failure (HP:0002878) | 2.27912600 |
| 85 | Gingivitis (HP:0000230) | 2.27716009 |
| 86 | Abnormality of eosinophils (HP:0001879) | 2.26586031 |
| 87 | Lipid accumulation in hepatocytes (HP:0006561) | 2.24855886 |
| 88 | Panhypogammaglobulinemia (HP:0003139) | 2.24781181 |
| 89 | Gonadotropin excess (HP:0000837) | 2.23401224 |
| 90 | Leukocytosis (HP:0001974) | 2.23016987 |
| 91 | Nausea (HP:0002018) | 2.22478925 |
| 92 | Osteolytic defects of the hand bones (HP:0009699) | 2.21681415 |
| 93 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.21681415 |
| 94 | Birth length less than 3rd percentile (HP:0003561) | 2.21259978 |
| 95 | Lymphoma (HP:0002665) | 2.20473095 |
| 96 | CNS demyelination (HP:0007305) | 2.20299794 |
| 97 | Carpal bone hypoplasia (HP:0001498) | 2.19565163 |
| 98 | Thrombocytosis (HP:0001894) | 2.17520906 |
| 99 | Hepatosplenomegaly (HP:0001433) | 2.16822115 |
| 100 | Methylmalonic aciduria (HP:0012120) | 2.16350282 |
| 101 | Leukopenia (HP:0001882) | 2.16279404 |
| 102 | Colitis (HP:0002583) | 2.14975288 |
| 103 | Dysostosis multiplex (HP:0000943) | 2.14646825 |
| 104 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.13562367 |
| 105 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.13562367 |
| 106 | Abnormality of T cell number (HP:0011839) | 2.12772895 |
| 107 | Skin ulcer (HP:0200042) | 2.11406635 |
| 108 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.08485337 |
| 109 | Prostate neoplasm (HP:0100787) | 2.07596447 |
| 110 | Periodontitis (HP:0000704) | 2.07369780 |
| 111 | Orchitis (HP:0100796) | 2.06023143 |
| 112 | Personality changes (HP:0000751) | 2.04603438 |
| 113 | T lymphocytopenia (HP:0005403) | 2.03638192 |
| 114 | Mutism (HP:0002300) | 2.01520627 |
| 115 | Thyroiditis (HP:0100646) | 2.01277961 |
| 116 | Exertional dyspnea (HP:0002875) | 1.99417897 |
| 117 | Abnormality of glycolysis (HP:0004366) | 1.99260914 |
| 118 | Loss of speech (HP:0002371) | 1.98691086 |
| 119 | Lethargy (HP:0001254) | 1.96722976 |
| 120 | Aplastic anemia (HP:0001915) | 1.96689923 |
| 121 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.96656219 |
| 122 | Papilloma (HP:0012740) | 1.96215678 |
| 123 | Verrucae (HP:0200043) | 1.96215678 |
| 124 | Glomerulonephritis (HP:0000099) | 1.96050289 |
| 125 | Small epiphyses (HP:0010585) | 1.95913973 |
| 126 | Abnormality of serum amino acid levels (HP:0003112) | 1.95853755 |
| 127 | Posterior subcapsular cataract (HP:0007787) | 1.95408014 |
| 128 | Spontaneous hematomas (HP:0007420) | 1.95086800 |
| 129 | Abnormality of the basal ganglia (HP:0002134) | 1.94921200 |
| 130 | Abnormality of chromosome stability (HP:0003220) | 1.93533919 |
| 131 | Hypoglycemic coma (HP:0001325) | 1.93392555 |
| 132 | Renal cortical cysts (HP:0000803) | 1.93288929 |
| 133 | Severe combined immunodeficiency (HP:0004430) | 1.92352014 |
| 134 | Sepsis (HP:0100806) | 1.92011005 |
| 135 | Inflammation of the large intestine (HP:0002037) | 1.91976822 |
| 136 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.91772366 |
| 137 | Recurrent cutaneous fungal infections (HP:0011370) | 1.91772366 |
| 138 | Disinhibition (HP:0000734) | 1.91659976 |
| 139 | Increased IgM level (HP:0003496) | 1.91372894 |
| 140 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.91314070 |
| 141 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.91023239 |
| 142 | Neutropenia (HP:0001875) | 1.90879782 |
| 143 | Mucosal telangiectasiae (HP:0100579) | 1.90640061 |
| 144 | Breast hypoplasia (HP:0003187) | 1.90592784 |
| 145 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.90455497 |
| 146 | Retrobulbar optic neuritis (HP:0100654) | 1.89066735 |
| 147 | Optic neuritis (HP:0100653) | 1.89066735 |
| 148 | Abnormal spermatogenesis (HP:0008669) | 1.89046305 |
| 149 | Tongue fasciculations (HP:0001308) | 1.88945792 |
| 150 | Respiratory difficulties (HP:0002880) | 1.86690716 |
| 151 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.86392182 |
| 152 | Amaurosis fugax (HP:0100576) | 1.86122794 |
| 153 | Nonimmune hydrops fetalis (HP:0001790) | 1.85991076 |
| 154 | Multiple enchondromatosis (HP:0005701) | 1.85142388 |
| 155 | Vertebral compression fractures (HP:0002953) | 1.84844539 |
| 156 | Stomatitis (HP:0010280) | 1.83868791 |
| 157 | Colon cancer (HP:0003003) | 1.80774240 |
| 158 | Hematochezia (HP:0002573) | 1.80666315 |
| 159 | Facial diplegia (HP:0001349) | 1.80315607 |
| 160 | Volvulus (HP:0002580) | 1.79673946 |
| 161 | Albinism (HP:0001022) | 1.78011048 |
| 162 | Constricted visual fields (HP:0001133) | 1.75886040 |
| 163 | Rhabdomyosarcoma (HP:0002859) | 1.75765160 |
| 164 | Abnormality of vitamin B metabolism (HP:0004340) | 1.74797665 |
| 165 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.73215536 |
| 166 | Renal Fanconi syndrome (HP:0001994) | 1.72833308 |
| 167 | Tubulointerstitial nephritis (HP:0001970) | 1.72382535 |
| 168 | Palpitations (HP:0001962) | 1.71216772 |
| 169 | Proximal tubulopathy (HP:0000114) | 1.70139318 |
| 170 | Dicarboxylic aciduria (HP:0003215) | 1.69151097 |
| 171 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.69151097 |
| 172 | Optic disc pallor (HP:0000543) | 1.68871893 |
| 173 | Symptomatic seizures (HP:0011145) | 1.68756751 |
| 174 | Congenital, generalized hypertrichosis (HP:0004540) | 1.66426567 |
| 175 | Breast carcinoma (HP:0003002) | 1.65625623 |
| 176 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.64408229 |
| 177 | Generalized aminoaciduria (HP:0002909) | 1.64111878 |
| 178 | Leukodystrophy (HP:0002415) | 1.63409990 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 3.44527392 |
| 2 | BUB1 | 3.44296176 |
| 3 | EIF2AK1 | 2.96981738 |
| 4 | MAP4K1 | 2.84666255 |
| 5 | EPHA2 | 2.81538435 |
| 6 | WEE1 | 2.76500074 |
| 7 | TRIM28 | 2.70091939 |
| 8 | EIF2AK3 | 2.45323238 |
| 9 | TYK2 | 2.12118785 |
| 10 | NUAK1 | 2.08845609 |
| 11 | MAP3K14 | 2.03361762 |
| 12 | PIM2 | 1.99000558 |
| 13 | VRK2 | 1.98975228 |
| 14 | BMPR1B | 1.95037809 |
| 15 | TESK2 | 1.88738590 |
| 16 | TBK1 | 1.88047820 |
| 17 | MKNK1 | 1.85092646 |
| 18 | ZAP70 | 1.84253449 |
| 19 | MST4 | 1.79268689 |
| 20 | SIK3 | 1.78569346 |
| 21 | NEK9 | 1.74876500 |
| 22 | FRK | 1.74356439 |
| 23 | NME2 | 1.72164188 |
| 24 | STK10 | 1.69453815 |
| 25 | NEK2 | 1.64072950 |
| 26 | IRAK4 | 1.63129224 |
| 27 | KDR | 1.60170092 |
| 28 | STK16 | 1.57674183 |
| 29 | IRAK3 | 1.56902088 |
| 30 | ARAF | 1.54227562 |
| 31 | CSF1R | 1.53777259 |
| 32 | BRSK2 | 1.52586590 |
| 33 | PLK2 | 1.51133807 |
| 34 | MKNK2 | 1.50949208 |
| 35 | GRK1 | 1.49496501 |
| 36 | TSSK6 | 1.47813821 |
| 37 | CDK19 | 1.47272411 |
| 38 | PBK | 1.45597212 |
| 39 | IKBKB | 1.43779558 |
| 40 | RPS6KA4 | 1.40272520 |
| 41 | ERN1 | 1.39998713 |
| 42 | WNK3 | 1.36784757 |
| 43 | ACVR1B | 1.36704485 |
| 44 | SYK | 1.31268545 |
| 45 | SCYL2 | 1.30920987 |
| 46 | KIT | 1.29122288 |
| 47 | TNIK | 1.27386533 |
| 48 | TESK1 | 1.26707071 |
| 49 | JAK3 | 1.26543688 |
| 50 | BTK | 1.26191386 |
| 51 | NEK1 | 1.25885866 |
| 52 | OXSR1 | 1.22967416 |
| 53 | TXK | 1.13783420 |
| 54 | IKBKE | 1.12537411 |
| 55 | JAK1 | 1.11178047 |
| 56 | TGFBR2 | 1.11113380 |
| 57 | PIM1 | 1.06276542 |
| 58 | ADRBK2 | 1.06134206 |
| 59 | LRRK2 | 1.03812842 |
| 60 | STK4 | 1.03136992 |
| 61 | RIPK4 | 1.02826910 |
| 62 | LYN | 0.99953534 |
| 63 | CDC7 | 0.99417616 |
| 64 | TAF1 | 0.98905806 |
| 65 | TTK | 0.97972274 |
| 66 | TEC | 0.96944352 |
| 67 | RPS6KB2 | 0.96268372 |
| 68 | BCR | 0.93130868 |
| 69 | DAPK1 | 0.92501086 |
| 70 | PLK4 | 0.91770837 |
| 71 | GRK6 | 0.90849499 |
| 72 | MAP3K3 | 0.90127405 |
| 73 | MAP3K8 | 0.89224113 |
| 74 | MAP4K2 | 0.88131771 |
| 75 | NLK | 0.87524640 |
| 76 | ZAK | 0.86264789 |
| 77 | MAP3K12 | 0.85998994 |
| 78 | EIF2AK2 | 0.85889858 |
| 79 | CDK4 | 0.83320491 |
| 80 | PASK | 0.82390341 |
| 81 | PLK1 | 0.81709015 |
| 82 | SRPK1 | 0.81189473 |
| 83 | HCK | 0.79089889 |
| 84 | MAP3K11 | 0.77767256 |
| 85 | FGFR4 | 0.76728400 |
| 86 | AURKB | 0.76021942 |
| 87 | PAK4 | 0.73979378 |
| 88 | MARK3 | 0.71983117 |
| 89 | FGR | 0.71674536 |
| 90 | LCK | 0.70398465 |
| 91 | TGFBR1 | 0.70029252 |
| 92 | CSNK1G1 | 0.69747019 |
| 93 | FER | 0.69684067 |
| 94 | FES | 0.69280984 |
| 95 | PDK2 | 0.68338386 |
| 96 | CSK | 0.65931165 |
| 97 | MAP2K3 | 0.65696323 |
| 98 | CSNK1G3 | 0.64475451 |
| 99 | GRK7 | 0.64137831 |
| 100 | CHUK | 0.63611787 |
| 101 | ATR | 0.63436816 |
| 102 | PRKCD | 0.62236502 |
| 103 | MAP3K13 | 0.62032607 |
| 104 | PLK3 | 0.60113560 |
| 105 | BRAF | 0.58068691 |
| 106 | STK38L | 0.57683454 |
| 107 | STK39 | 0.57020297 |
| 108 | BMPR2 | 0.56693697 |
| 109 | TLK1 | 0.53103045 |
| 110 | PRKCI | 0.52665257 |
| 111 | AURKA | 0.52401319 |
| 112 | BRSK1 | 0.51069870 |
| 113 | CCNB1 | 0.49622260 |
| 114 | PRKCE | 0.49471209 |
| 115 | CSNK1G2 | 0.49200501 |
| 116 | STK24 | 0.48674241 |
| 117 | CDK6 | 0.48015847 |
| 118 | MAP3K10 | 0.47789335 |
| 119 | YES1 | 0.47641276 |
| 120 | MAPKAPK2 | 0.46318887 |
| 121 | CAMKK2 | 0.46313485 |
| 122 | EGFR | 0.45982028 |
| 123 | CSNK2A1 | 0.45436587 |
| 124 | PAK1 | 0.44564635 |
| 125 | VRK1 | 0.43878156 |
| 126 | FLT3 | 0.43401343 |
| 127 | ITK | 0.42936670 |
| 128 | EPHA3 | 0.42589992 |
| 129 | ATM | 0.42020528 |
| 130 | BCKDK | 0.40892064 |
| 131 | STK3 | 0.40233960 |
| 132 | ABL1 | 0.40222947 |
| 133 | ERBB3 | 0.39592225 |
| 134 | IGF1R | 0.38953699 |
| 135 | MAPKAPK3 | 0.37851636 |
| 136 | MATK | 0.37201842 |
| 137 | CSNK2A2 | 0.36256775 |
| 138 | CDK9 | 0.35396548 |
| 139 | ALK | 0.34782895 |
| 140 | CLK1 | 0.34758018 |
| 141 | CSNK1A1L | 0.34273848 |
| 142 | CHEK2 | 0.30499059 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.40906001 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 2.66884132 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.41933412 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.29618776 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.22088758 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.18779811 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.17781861 |
| 8 | Legionellosis_Homo sapiens_hsa05134 | 2.09587940 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.03228456 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 1.96156380 |
| 11 | Lysosome_Homo sapiens_hsa04142 | 1.94678341 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 1.86085186 |
| 13 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.81847032 |
| 14 | RNA polymerase_Homo sapiens_hsa03020 | 1.81598174 |
| 15 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.78958375 |
| 16 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.76351463 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.75175549 |
| 18 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.71358305 |
| 19 | Other glycan degradation_Homo sapiens_hsa00511 | 1.71075046 |
| 20 | Homologous recombination_Homo sapiens_hsa03440 | 1.70809257 |
| 21 | Ribosome_Homo sapiens_hsa03010 | 1.69704319 |
| 22 | RNA transport_Homo sapiens_hsa03013 | 1.69167737 |
| 23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.66783281 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.64501655 |
| 25 | Parkinsons disease_Homo sapiens_hsa05012 | 1.61563345 |
| 26 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.60252488 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.56658220 |
| 28 | Measles_Homo sapiens_hsa05162 | 1.54506402 |
| 29 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.53714232 |
| 30 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.51537520 |
| 31 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.46986035 |
| 32 | Spliceosome_Homo sapiens_hsa03040 | 1.44604275 |
| 33 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.44033705 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.43020315 |
| 35 | Allograft rejection_Homo sapiens_hsa05330 | 1.43018651 |
| 36 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.40245651 |
| 37 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.35611069 |
| 38 | Cell cycle_Homo sapiens_hsa04110 | 1.33219390 |
| 39 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.30892621 |
| 40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.29544517 |
| 41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.29108555 |
| 42 | Tuberculosis_Homo sapiens_hsa05152 | 1.29012645 |
| 43 | Shigellosis_Homo sapiens_hsa05131 | 1.27499638 |
| 44 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.26211862 |
| 45 | Pertussis_Homo sapiens_hsa05133 | 1.24932015 |
| 46 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.24829370 |
| 47 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.23488759 |
| 48 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.20355252 |
| 49 | Influenza A_Homo sapiens_hsa05164 | 1.20284834 |
| 50 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.18965963 |
| 51 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.18517134 |
| 52 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.18172159 |
| 53 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.17816662 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.16513846 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.16232362 |
| 56 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.14418949 |
| 57 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.14127593 |
| 58 | Apoptosis_Homo sapiens_hsa04210 | 1.13845193 |
| 59 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.12408779 |
| 60 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.11637330 |
| 61 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.10797795 |
| 62 | Peroxisome_Homo sapiens_hsa04146 | 1.09780409 |
| 63 | Phagosome_Homo sapiens_hsa04145 | 1.09169787 |
| 64 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.05233542 |
| 65 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.04436958 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.01117230 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.00948282 |
| 68 | Malaria_Homo sapiens_hsa05144 | 0.97642748 |
| 69 | Huntingtons disease_Homo sapiens_hsa05016 | 0.96087671 |
| 70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.95837232 |
| 71 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.88584282 |
| 72 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.88178417 |
| 73 | Carbon metabolism_Homo sapiens_hsa01200 | 0.85391673 |
| 74 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.85169423 |
| 75 | Asthma_Homo sapiens_hsa05310 | 0.85018424 |
| 76 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.84288214 |
| 77 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.83924196 |
| 78 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.82449403 |
| 79 | Salmonella infection_Homo sapiens_hsa05132 | 0.82325296 |
| 80 | Alzheimers disease_Homo sapiens_hsa05010 | 0.82254267 |
| 81 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.81303879 |
| 82 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.81035502 |
| 83 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.80230199 |
| 84 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78158353 |
| 85 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.74943876 |
| 86 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.74761210 |
| 87 | Hepatitis B_Homo sapiens_hsa05161 | 0.72824901 |
| 88 | Protein export_Homo sapiens_hsa03060 | 0.72274755 |
| 89 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.70089681 |
| 90 | Basal transcription factors_Homo sapiens_hsa03022 | 0.69009538 |
| 91 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.68302317 |
| 92 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.68039590 |
| 93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.67623806 |
| 94 | RNA degradation_Homo sapiens_hsa03018 | 0.66673621 |
| 95 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.66124327 |
| 96 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.65618489 |
| 97 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.65417956 |
| 98 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.64503362 |
| 99 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.64449214 |
| 100 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.64352951 |
| 101 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.63384256 |
| 102 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63371286 |
| 103 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.62091207 |
| 104 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.62073019 |
| 105 | Hepatitis C_Homo sapiens_hsa05160 | 0.60789689 |
| 106 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.59722955 |
| 107 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.59532023 |
| 108 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.58390576 |
| 109 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.57196230 |
| 110 | Purine metabolism_Homo sapiens_hsa00230 | 0.57018265 |
| 111 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56900286 |
| 112 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56833293 |
| 113 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54608266 |
| 114 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.51831837 |
| 115 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.51514947 |
| 116 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.51430865 |
| 117 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.49376447 |
| 118 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.48868218 |
| 119 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.48779354 |
| 120 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48747130 |
| 121 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.46649597 |
| 122 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.46250758 |
| 123 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.46194656 |
| 124 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44995899 |
| 125 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.43945439 |
| 126 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.43944953 |
| 127 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.42279172 |
| 128 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.41390349 |
| 129 | * Endocytosis_Homo sapiens_hsa04144 | 0.40849481 |
| 130 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.40748974 |
| 131 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.39446096 |
| 132 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.38758699 |
| 133 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.37246141 |
| 134 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.37069024 |
| 135 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.35814392 |
| 136 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.34589367 |
| 137 | Phototransduction_Homo sapiens_hsa04744 | 0.28349781 |

